PT2531518T - Compostos oligopeptídicos e suas utilizações - Google Patents
Compostos oligopeptídicos e suas utilizaçõesInfo
- Publication number
- PT2531518T PT2531518T PT117016782T PT11701678T PT2531518T PT 2531518 T PT2531518 T PT 2531518T PT 117016782 T PT117016782 T PT 117016782T PT 11701678 T PT11701678 T PT 11701678T PT 2531518 T PT2531518 T PT 2531518T
- Authority
- PT
- Portugal
- Prior art keywords
- oligopeptidic compounds
- oligopeptidic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- AIDS & HIV (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001602.0A GB201001602D0 (en) | 2010-02-01 | 2010-02-01 | Oligopeptidic compounds and uses therof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2531518T true PT2531518T (pt) | 2016-08-12 |
Family
ID=42084276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117016782T PT2531518T (pt) | 2010-02-01 | 2011-02-01 | Compostos oligopeptídicos e suas utilizações |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8754042B2 (pt) |
| EP (1) | EP2531518B1 (pt) |
| JP (1) | JP5934654B2 (pt) |
| KR (1) | KR101848518B1 (pt) |
| CN (1) | CN102781953B (pt) |
| CA (1) | CA2788726C (pt) |
| CY (1) | CY1117872T1 (pt) |
| DK (1) | DK2531518T3 (pt) |
| ES (1) | ES2585595T3 (pt) |
| GB (1) | GB201001602D0 (pt) |
| HR (1) | HRP20160922T1 (pt) |
| HU (1) | HUE028094T2 (pt) |
| LT (1) | LT2531518T (pt) |
| PL (1) | PL2531518T3 (pt) |
| PT (1) | PT2531518T (pt) |
| RS (1) | RS54992B1 (pt) |
| SI (1) | SI2531518T1 (pt) |
| SM (1) | SMT201600261B (pt) |
| WO (1) | WO2011092347A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201001602D0 (en) | 2010-02-01 | 2010-03-17 | Cytovation As | Oligopeptidic compounds and uses therof |
| CN103012562B (zh) * | 2011-09-24 | 2015-01-28 | 复旦大学 | 一种双重靶向的d构型多肽及其递药系统 |
| WO2013139861A1 (en) | 2012-03-20 | 2013-09-26 | Luc Montagnier | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| CN103720655B (zh) * | 2012-10-11 | 2016-05-25 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种d型多肽介导的靶向脂质体及其制备方法和应用 |
| KR101782634B1 (ko) * | 2015-06-29 | 2017-10-25 | 주식회사 큐라클 | Amigo2와 3-포스포이노시티드-의존 키나아제 1의 결합 억제용 데코이 펩타이드 |
| PE20191785A1 (es) * | 2017-03-16 | 2019-12-24 | Microsintesis Inc | Composiciones y metodos que involucran moleculas probioticas |
| CN108314741B (zh) * | 2018-03-22 | 2021-08-03 | 中国人民解放军第四军医大学 | 一种肿瘤血管靶向抗癌肽nkl-dota及其制备方法 |
| GB201810058D0 (en) * | 2018-06-19 | 2018-08-08 | Cytovation As | Combination therapy using a peptide |
| KR102073144B1 (ko) * | 2018-12-13 | 2020-02-04 | 주식회사 엘베이스 | 올리고펩티드를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 |
| EP3964520A4 (en) * | 2019-05-02 | 2023-05-10 | L-Base Co.,Ltd. | NEW OLIGOPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER USING IT AS AN ACTIVE SUBSTANCE |
| CN110408699A (zh) * | 2019-07-11 | 2019-11-05 | 福建卫生职业技术学院 | 肠癌肠道菌群标志物及其应用 |
| GB202000167D0 (en) | 2020-01-07 | 2020-02-19 | Cytovation As | Composition for treatment of neoplastic lesions |
| CN115044520B (zh) * | 2022-08-12 | 2022-11-15 | 北京百奥茵诺生物科技有限公司 | 一株交替单胞菌及使用其生产单葡萄糖醛酸甘草次酸的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3925542A1 (de) | 1989-08-02 | 1990-02-15 | Kallos Verlag Und Versand Gmbh | Glueckwunschkarte |
| US5534110A (en) | 1993-07-30 | 1996-07-09 | Lam Research Corporation | Shadow clamp |
| US5595756A (en) | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| FR2739621B1 (fr) | 1995-10-05 | 1997-12-05 | Centre Nat Rech Scient | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives |
| DE19840875A1 (de) | 1997-09-02 | 1999-05-12 | Max Delbrueck Centrum | Mittel zur Diagnose und zur Therapie von Tumorerkrankungen |
| WO1999029721A1 (en) | 1997-12-10 | 1999-06-17 | Washington University | Anti-pathogen system and methods of use thereof |
| GB9814527D0 (en) | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
| HUP0204199A3 (en) | 1998-11-13 | 2005-09-28 | Cyclacel Ltd | Transport vectors |
| FR2849603B1 (fr) | 2003-01-07 | 2006-09-08 | Centre Nat Rech Scient | Composition pour le transport intracellulaire de macromolecules ou particules biologiques |
| US7442681B2 (en) * | 2004-02-10 | 2008-10-28 | University Of Virginia Patent Foundation | Method of inhibiting vascular permeability |
| US8680041B2 (en) * | 2006-10-26 | 2014-03-25 | Genentech, Inc. | Genetic variations associated with tumors |
| KR20080038047A (ko) * | 2006-10-27 | 2008-05-02 | 김정문 | 세포핵에서 세포질로의 ｇｓｋ３ 이동을 억제하는 방법 및물질 |
| GB0803352D0 (en) * | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| GB201001602D0 (en) | 2010-02-01 | 2010-03-17 | Cytovation As | Oligopeptidic compounds and uses therof |
-
2010
- 2010-02-01 GB GBGB1001602.0A patent/GB201001602D0/en not_active Ceased
-
2011
- 2011-02-01 LT LTEP11701678.2T patent/LT2531518T/lt unknown
- 2011-02-01 SI SI201130904A patent/SI2531518T1/sl unknown
- 2011-02-01 US US13/574,124 patent/US8754042B2/en active Active
- 2011-02-01 WO PCT/EP2011/051422 patent/WO2011092347A1/en active Application Filing
- 2011-02-01 KR KR1020127022641A patent/KR101848518B1/ko active IP Right Grant
- 2011-02-01 ES ES11701678.2T patent/ES2585595T3/es active Active
- 2011-02-01 CA CA2788726A patent/CA2788726C/en active Active
- 2011-02-01 JP JP2012550478A patent/JP5934654B2/ja active Active
- 2011-02-01 EP EP11701678.2A patent/EP2531518B1/en active Active
- 2011-02-01 PT PT117016782T patent/PT2531518T/pt unknown
- 2011-02-01 DK DK11701678.2T patent/DK2531518T3/en active
- 2011-02-01 CN CN201180008036.9A patent/CN102781953B/zh active Active
- 2011-02-01 HU HUE11701678A patent/HUE028094T2/en unknown
- 2011-02-01 RS RS20160608A patent/RS54992B1/sr unknown
- 2011-02-01 PL PL11701678T patent/PL2531518T3/pl unknown
-
2014
- 2014-06-16 US US14/305,743 patent/US9353156B2/en active Active
-
2016
- 2016-07-21 HR HRP20160922TT patent/HRP20160922T1/hr unknown
- 2016-08-03 CY CY20161100763T patent/CY1117872T1/el unknown
- 2016-08-03 SM SM201600261T patent/SMT201600261B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2788726C (en) | 2019-04-02 |
| WO2011092347A1 (en) | 2011-08-04 |
| KR20120128135A (ko) | 2012-11-26 |
| LT2531518T (lt) | 2016-09-26 |
| HUE028094T2 (en) | 2016-11-28 |
| JP2013517787A (ja) | 2013-05-20 |
| CA2788726A1 (en) | 2011-08-04 |
| EP2531518A1 (en) | 2012-12-12 |
| US8754042B2 (en) | 2014-06-17 |
| EP2531518B1 (en) | 2016-05-04 |
| KR101848518B1 (ko) | 2018-04-12 |
| GB201001602D0 (en) | 2010-03-17 |
| DK2531518T3 (en) | 2016-08-15 |
| CN102781953A (zh) | 2012-11-14 |
| US20150038407A1 (en) | 2015-02-05 |
| SI2531518T1 (sl) | 2016-09-30 |
| JP5934654B2 (ja) | 2016-06-15 |
| ES2585595T3 (es) | 2016-10-06 |
| HRP20160922T1 (hr) | 2016-10-07 |
| RS54992B1 (sr) | 2016-11-30 |
| US20130023461A1 (en) | 2013-01-24 |
| US9353156B2 (en) | 2016-05-31 |
| CN102781953B (zh) | 2015-02-04 |
| SMT201600261B (it) | 2016-11-10 |
| CY1117872T1 (el) | 2017-05-17 |
| PL2531518T3 (pl) | 2017-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
| HK1206004A1 (en) | Ingenol-3-acylates iii and ingenol-3-carbamates -3- iii -3- | |
| IL220939A0 (en) | Compounds and methods | |
| EP2523664A4 (en) | COMPOUNDS AND METHODS | |
| HRP20160922T1 (hr) | Oligopeptidni spojevi i njihove uporabe | |
| IL220812A0 (en) | Compounds and methods | |
| ZA201303773B (en) | Compounds and their use | |
| EP2523560A4 (en) | CONNECTIONS AND METHODS | |
| EP2575453A4 (en) | OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE | |
| EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
| GB201111775D0 (en) | Compounds and uses thereof | |
| EP2529013A4 (en) | NOVEL BETA GLUCOSIDASE AND USES THEREOF | |
| EP2615094A4 (en) | SESTERTERPEN COMPOUNDS AND THEIR USE | |
| GB201004450D0 (en) | Compounds and methods relating thereto | |
| SG10201508549UA (en) | Modified tamavidin | |
| GB201014319D0 (en) | Compounds and uses thereof | |
| GB201020848D0 (en) | Compounds and their use | |
| GB201018028D0 (en) | Compounds and their use | |
| GB201017822D0 (en) | Compounds and their use | |
| GB201005511D0 (en) | Compounds and their use | |
| GB201002337D0 (en) | Compounds and their use | |
| GB201000309D0 (en) | Compounds and their use | |
| GB201000307D0 (en) | Compounds and their use | |
| GB201000305D0 (en) | Compounds and their use | |
| GB201000308D0 (en) | Compounds and their use |